BAIN CAPITAL INVESTORS LLC

Q4 2023 13F-HR Holdings

Location
Boston, MA
Holdings as of
12/31/2023
Date filed
2/13/2024
Form type
13F-HR
Num holdings
4
Total value ($000)
$4,611,779
Net value change ($000)
+1,488,545 (47.7%)
New positions
0
Sold out positions
0
Turnover %
0.0%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/14/2023 Next filing: 5/15/2024 SEC filing

Snapshot: Change Analysis

Compared to Q3 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Cerevel Therapeutics Holdings, Inc. 1,470,663 111.9%
AVAH 121,585 125.2%
ADV 2,254 27.5%
Top Reduces (Value $000, Stocks/ETFs)
SGRY -105,957 -6.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type